Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:          
Net loss $ (16,654) $ (4,097) $ (25,761) $ (26,141)  
Adjustments to reconcile net loss to cash used in operating activities:          
Depreciation and amortization     1,276 1,584  
Stock-based compensation expense 927 724 1,697 1,586  
Change in fair value of warrant liabilities 8,629 (4,198) 6,364 (2,945)  
Non-cash impairment of licensed technology 1,355  
Non-cash loss/(gain) of right-of-use lease assets     (1,065) 1,561  
Non-cash impairment of construction-in-progress     1,792  
Accretion and interest on short-term investments     (74) (177)  
Amortization of right-of-use lease assets     450 899  
Non-cash interest     204 402  
Loss on disposal of property and equipment     47 106  
Change in operating assets and liabilities:          
Accounts receivable     (3,500) 2,000  
Other receivables     (2,039) (1,827)  
Prepaid expenses and other current assets     (777) 937  
Other assets     (65) 148  
Accounts payable, accrued expenses and lease liabilities     1,214 (3,684)  
Other current liabilities     1  
Change in payable to licensor     (296)  
Net cash used in operating activities     (22,028) (22,700)  
Cash flows from investing activities:          
Capital expenditures     (250) (103)  
Proceeds from disposal of property and equipment     179 1,487  
Purchases of short-term investments     (14,156) (34,442)  
Proceeds from maturities of short-term investments     21,649 32,735  
Net cash provided by (used in) investing activities     7,422 (323)  
Cash flows from financing activities:          
Proceeds from ATM sales of common stock, net of issuance costs     6,623  
Proceeds from net settlement of restricted share awards     (9)  
Proceeds from issuance of Series A and Series B Convertible Redeemable Preferred Stock, net of issuance costs     22,468  
Redemption of Series A and Series B Convertible Redeemable Preferred Stock     (26,250)  
Net cash provided by (used in) financing activities     6,614 (3,782)  
Net decrease in cash, cash equivalents and restricted cash     (7,992) (26,805)  
Cash, cash equivalents and restricted cash at beginning of period     14,555 38,829 $ 38,829
Cash, cash equivalents and restricted cash at end of period 6,563 12,024 6,563 12,024 14,555
Supplemental cash flow information:          
Cash and cash equivalents 6,225 6,133 6,225 6,133 $ 14,217
Restricted cash 338 5,891 338 5,891  
Total cash, cash equivalents and restricted cash $ 6,563 $ 12,024 6,563 12,024  
Supplemental non-cash flow information:          
Right-of-use asset obtained in exchange for new operating lease liabilities     $ 419